AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
New Fortress Energy
NFE
Cars.com
CARS
4
Halozyme Therapeutics
HALO
5
Collegium Pharmaceutical
COLL
US Stock MarketDetailed Quotes
BDTX Black Diamond Therapeutics
- 1.780
- -0.100-5.32%
Close Mar 21 16:00 ET
- 1.730
- -0.050-2.81%
Post 20:01 ET
100.86MMarket Cap-1.40P/E (TTM)
1.830High1.670Low5.99MVolume1.800Open1.880Pre Close10.55MTurnover15.37%Turnover RatioLossP/E (Static)56.66MShares7.66052wk High1.21P/B69.42MFloat Cap1.59052wk Low--Dividend TTM39.00MShs Float46.250Historical High--Div YieldTTM8.51%Amplitude1.180Historical Low1.760Avg Price1Lot Size
Black Diamond Therapeutics News
Black Diamond Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Behbahani Ali
Black Diamond Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Raman Prakash
Black Diamond Therapeutics | SCHEDULE 13G/A: Others
Black Diamond Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner BIOTECH GROWTH N V
Black Diamond Therapeutics | 8-K: Current report
Black Diamond Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Black Diamond Therapeutics | 10-K: FY2024 Annual Report
Black Diamond Therapeutics | 8-K: Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
Black Diamond Therapeutics | SCHEDULE 13G/A: Others
Black Diamond Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Velleca Mark A.
Black Diamond Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Yurasov Sergey
Black Diamond Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Buck Elizabeth
Black Diamond Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Jones Erika
Black Diamond Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Hatzis-Schoch Brent
Black Diamond Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Behbahani Ali
Black Diamond Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Raman Prakash
Black Diamond Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Campbell Shannon
Black Diamond Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-T. Rowe Price Investment Management, Inc.(19.0%)
Black Diamond Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Vestal Point Capital, LP(8.9%),Ryan Wilder(8.9%)
Black Diamond Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-BlackRock, Inc.(6.2%)
Market Insights
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings